Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-05 5:27 pm Unchanged |
2024-01-03 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 63,087 4.300% |
0 (Unchanged) |
Filing History |
| 2023-09-15 12:00 pm Unchanged |
2023-09-15 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 4.780% |
0 (Unchanged) |
Filing History |
| 2023-09-11 8:54 pm Purchase |
2023-08-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 73,559 5.100% |
73,559 (New Position) |
Filing History |
| 2023-09-08 12:47 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
Perceptive Advisors LLC | 145,111 9.900% |
117,111 (+418.25%) |
Filing History |
| 2023-08-23 4:47 pm Purchase |
2023-08-16 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 63,087 4.300% |
10,416 (+19.77%) |
Filing History |
| 2023-08-15 5:15 pm Purchase |
2023-07-31 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 76,048 5.210% |
24,886 (+48.64%) |
Filing History |
| 2023-08-10 4:34 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
BIOTECHNOLOGY VALUE FUND L P | 119,284 8.200% |
119,284 (New Position) |
Filing History |
| 2023-08-10 3:57 pm Purchase |
2023-07-31 | 13G | Forte Biosciences, Inc. FBRX |
Farallon Capital Partners, L.P. | 151,505 9.900% |
151,505 (New Position) |
Filing History |
| 2023-08-10 09:20 am Unchanged |
2023-08-18 | 13D | Forte Biosciences, Inc. FBRX |
ATG Fund II LLC | 58,480 4.000% |
0 (Unchanged) |
Filing History |
| 2023-08-03 4:31 pm Sale |
2023-08-01 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 52,671 3.600% |
-19,837 (-27.36%) |
Filing History |
| 2023-07-06 4:08 pm Unchanged |
2023-07-06 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 9.650% |
0 (Unchanged) |
Filing History |
| 2023-07-05 4:54 pm Unchanged |
2023-07-03 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 72,508 8.600% |
0 (Unchanged) |
Filing History |
| 2023-05-25 3:49 pm Unchanged |
2023-05-25 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 72,508 8.600% |
0 (Unchanged) |
Filing History |
| 2023-04-10 08:05 am Purchase |
2023-03-30 | 13G | Forte Biosciences, Inc. FBRX |
JEC II Associates LLC | 45,640 5.430% |
45,640 (New Position) |
Filing History |
| 2023-03-29 11:17 am Purchase |
2023-03-24 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 8.260% |
10,948 (+18.73%) |
Filing History |
| 2023-02-21 5:15 pm Purchase |
2023-02-17 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 72,508 8.600% |
5,421 (+8.08%) |
Filing History |
| 2022-09-28 5:22 pm Purchase |
2022-09-26 | 13D | Forte Biosciences, Inc. FBRX |
Camac Fund LP | 67,087 8.200% |
9,016 (+15.53%) |
Filing History |
| 2022-09-22 09:01 am Purchase |
2022-09-15 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 81,279 9.990% |
15,998 (+24.51%) |
Filing History |
| 2022-09-12 5:11 pm Sale |
2022-08-31 | 13G | Forte Biosciences, Inc. FBRX |
MORGAN STANLEY MS |
9,084 1.100% |
-35,365 (-79.56%) |
Filing History |
| 2022-08-24 4:20 pm Purchase |
2022-08-24 | 13D | Forte Biosciences, Inc. FBRX |
Funicular Funds, LP | 65,281 8.000% |
6,826 (+11.68%) |
Filing History |